|
2018-10-09 |
2018-10-09 |
PS
Planned sale
|
Andriole Michael T.
Chief Financial Officer
Officer
|
635
-0.5%
15.85
USD 10,065
|
635
-0.5%
|
15.85
|
USD 10,065
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Low Philip S
Chief Science Officer
Executive Director
|
5,928
-1.8%
15.56
USD 92,238
|
5,928
-1.8%
|
15.56
|
USD 92,238
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Armour Alison A.
Chief Medical Officer
Officer
|
9,111
-8.3%
15.56
USD 141,748
|
9,111
-8.3%
|
15.56
|
USD 141,748
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
7,022
-11.1%
15.56
USD 109,287
|
7,022
-11.1%
|
15.56
|
USD 109,287
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
9,028
-6.9%
15.56
USD 140,437
|
9,028
-6.9%
|
15.56
|
USD 140,437
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Andriole Michael T.
Chief Financial Officer
Officer
|
17,283
-11.5%
15.55
USD 268,783
|
17,283
-11.5%
|
15.55
|
USD 268,783
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Sherman Michael A.
President and CEO
Executive Director
|
28,146
-7.5%
15.55
USD 437,752
|
28,146
-7.5%
|
15.55
|
USD 437,752
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Chelius Erik C.
Vice President CMC
Officer
|
4,514
-8.3%
15.56
USD 70,243
|
4,514
-8.3%
|
15.56
|
USD 70,243
|
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Parker Katherine
VP of Human Resources
Officer
|
6,771
-8.8%
15.55
USD 105,316
|
6,771
-8.8%
|
15.55
|
USD 105,316
|
|
|
2018-08-29 |
2018-08-29 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
4,696
-3.5%
20.00
USD 93,920
|
4,696
-3.5%
|
20.00
|
USD 93,920
|
|
|
2018-08-29 |
2018-08-28 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
7,892
-11.1%
20.00
USD 157,840
|
7,892
-11.1%
|
20.00
|
USD 157,840
|
|
|
2018-08-29 |
2018-08-28 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
12,670
-8.9%
20.00
USD 253,403
|
12,670
-8.9%
|
20.00
|
USD 253,403
|
|
|
2018-08-22 |
2018-08-20 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
285
-0.4%
18.20
USD 5,187
|
285
-0.4%
|
18.20
|
USD 5,187
|
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
Armour Alison A.
Chief Medical Officer
Officer
|
1,414
-1.3%
15.98
USD 22,589
|
1,414
-1.3%
|
15.98
|
USD 22,589
|
|
|
2018-06-13 |
2018-06-12 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
|
13,089
-9.1%
15.06
USD 197,058
|
13,089
-9.1%
|
15.06
|
USD 197,058
|
|
|
2018-03-12 |
2018-03-09 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
|
5,036
-3.4%
9.07
USD 45,677
|
5,036
-3.4%
|
9.07
|
USD 45,677
|
|
|
2018-01-02 |
2017-12-28 |
S
Sale
|
Low Philip S
Chief Science Officer
Executive Director
|
50,511
-14.3%
4.41
USD 222,824
|
50,511
-14.3%
|
4.41
|
USD 222,824
|
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
Leamon Christopher P
Vice President of Research
|
5,037
-3.8%
5.05
USD 25,434
|
5,037
-3.8%
|
5.05
|
USD 25,434
|
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
Leamon Christopher P
Vice President of Research
|
18,194
-12.1%
5.03
USD 91,549
|
18,194
-12.1%
|
5.03
|
USD 91,549
|
|
|
2017-11-14 |
2017-11-13 |
B
Purchase
|
Low Philip S
Chief Science Officer
Executive Director
|
5,600
+2.0%
4.84
USD 27,104
|
5,600
+2.0%
|
4.84
|
USD 27,104
|
|
|
2017-01-04 |
2016-12-30 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
23,244
-25.8%
2.55
USD 59,272
|
23,244
-25.8%
|
2.55
|
USD 59,272
|
|
|
2016-05-12 |
2016-05-10 |
B
Purchase
|
Low Philip S
Chief Science Officer
Executive Director
|
11,375
+5.5%
3.52
USD 40,040
|
11,375
+5.5%
|
3.52
|
USD 40,040
|
|
|
2016-01-20 |
2016-01-19 |
B
Purchase
|
MIDDLETON FRED A
Non-Executive Director
|
10,000
+5.2%
2.79
USD 27,900
|
10,000
+5.2%
|
2.79
|
USD 27,900
|
|
|
2016-01-20 |
2016-01-15 |
B
Purchase
|
MIDDLETON FRED A
Non-Executive Director
|
20,000
+11.7%
2.80
USD 56,000
|
20,000
+11.7%
|
2.80
|
USD 56,000
|
|
|
2015-03-05 |
2015-03-03 |
S
Sale
|
Nguyen Binh
VP of Medical Affairs
Officer
|
29,883
-51.3%
5.79
USD 172,987
|
29,883
-51.3%
|
5.79
|
USD 172,987
|
|
|
2014-08-13 |
2014-08-11 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
21,479
-77.5%
7.00
USD 150,353
|
21,479
-77.5%
|
7.00
|
USD 150,353
|
|
|
2013-09-16 |
2013-09-12 |
S
Sale
|
Meek David D.
Chief Commercial Officer
Officer
|
10,000
-100.0%
15.50
USD 155,000
|
10,000
-100.0%
|
15.50
|
USD 155,000
|
|
|
2013-09-04 |
2013-08-30 |
S
Sale
|
Ritter Allen R
VP of Manufacturing/CMC
Officer
|
6,000
-25.3%
14.36
USD 86,160
|
6,000
-25.3%
|
14.36
|
USD 86,160
|
|
|
2013-08-08 |
2013-08-06 |
S
Sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
7,000
-100.0%
17.29
USD 121,030
|
7,000
-100.0%
|
17.29
|
USD 121,030
|
|
|
2013-05-29 |
2013-05-28 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
131
-0.2%
14.25
USD 1,867
|
131
-0.2%
|
14.25
|
USD 1,867
|
|
|
2013-05-29 |
2013-05-28 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,569
-0.2%
14.25
USD 22,358
|
1,569
-0.2%
|
14.25
|
USD 22,358
|
|
|
2013-05-29 |
2013-05-24 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
630
-1.1%
14.07
USD 8,864
|
630
-1.1%
|
14.07
|
USD 8,864
|
|
|
2013-05-29 |
2013-05-24 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
7,570
-1.1%
14.07
USD 106,510
|
7,570
-1.1%
|
14.07
|
USD 106,510
|
|
|
2013-05-22 |
2013-05-22 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,259
-2.2%
14.39
USD 18,117
|
1,259
-2.2%
|
14.39
|
USD 18,117
|
|
|
2013-05-22 |
2013-05-22 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
15,141
-2.2%
14.39
USD 217,879
|
15,141
-2.2%
|
14.39
|
USD 217,879
|
|
|
2013-05-22 |
2013-05-21 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
845
-1.5%
14.31
USD 12,092
|
845
-1.5%
|
14.31
|
USD 12,092
|
|
|
2013-05-22 |
2013-05-21 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
10,155
-1.5%
14.31
USD 145,318
|
10,155
-1.5%
|
14.31
|
USD 145,318
|
|
|
2013-05-22 |
2013-05-20 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
967
-1.7%
14.42
USD 13,944
|
967
-1.7%
|
14.42
|
USD 13,944
|
|
|
2013-05-22 |
2013-05-20 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
11,633
-1.7%
14.42
USD 167,748
|
11,633
-1.7%
|
14.42
|
USD 167,748
|
|
|
2013-05-21 |
2013-05-17 |
S
Sale
|
Nguyen Binh
VP of Clinical Affairs
Officer
|
17,300
-100.0%
14.42
USD 249,466
|
17,300
-100.0%
|
14.42
|
USD 249,466
|
|
|
2013-05-20 |
2013-05-17 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,121
-1.9%
14.37
USD 16,109
|
1,121
-1.9%
|
14.37
|
USD 16,109
|
|
|
2013-05-20 |
2013-05-17 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
13,479
-1.9%
14.37
USD 193,693
|
13,479
-1.9%
|
14.37
|
USD 193,693
|
|
|
2013-05-20 |
2013-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,735
-2.9%
14.44
USD 25,053
|
1,735
-2.9%
|
14.44
|
USD 25,053
|
|
|
2013-05-20 |
2013-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
20,865
-2.9%
14.44
USD 301,291
|
20,865
-2.9%
|
14.44
|
USD 301,291
|
|
|
2013-05-16 |
2013-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,536
-2.5%
14.43
USD 22,164
|
1,536
-2.5%
|
14.43
|
USD 22,164
|
|
|
2013-05-16 |
2013-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
18,464
-2.5%
14.43
USD 266,436
|
18,464
-2.5%
|
14.43
|
USD 266,436
|
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,551
-2.4%
14.94
USD 23,172
|
1,551
-2.4%
|
14.94
|
USD 23,172
|
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
18,649
-2.4%
14.94
USD 278,616
|
18,649
-2.4%
|
14.94
|
USD 278,616
|
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
5,000
-33.2%
14.70
USD 73,500
|
5,000
-33.2%
|
14.70
|
USD 73,500
|
|
|
2013-02-26 |
2013-02-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,993
-100.0%
9.70
USD 19,332
|
1,993
-100.0%
|
9.70
|
USD 19,332
|
|
|
2013-02-26 |
2013-02-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
109
-100.0%
9.70
USD 1,057
|
109
-100.0%
|
9.70
|
USD 1,057
|
|
|
2013-02-20 |
2013-02-19 |
PS
Planned sale
|
Ritter Allen R
VP of Manufacturing/CMC
Officer
|
500
-14.4%
10.03
USD 5,015
|
500
-14.4%
|
10.03
|
USD 5,015
|
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,659
-100.0%
9.56
USD 15,860
|
1,659
-100.0%
|
9.56
|
USD 15,860
|
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
443
-100.0%
9.56
USD 4,235
|
443
-100.0%
|
9.56
|
USD 4,235
|
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
107
-100.0%
9.56
USD 1,023
|
107
-100.0%
|
9.56
|
USD 1,023
|
|
|
2012-12-28 |
2012-12-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,102
-100.0%
9.05
USD 19,023
|
2,102
-100.0%
|
9.05
|
USD 19,023
|
|
|
2012-12-28 |
2012-12-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
107
-100.0%
9.05
USD 968
|
107
-100.0%
|
9.05
|
USD 968
|
|
|
2012-11-27 |
2012-11-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,926
-100.0%
8.72
USD 16,795
|
1,926
-100.0%
|
8.72
|
USD 16,795
|
|
|
2012-11-27 |
2012-11-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
283
-100.0%
8.72
USD 2,468
|
283
-100.0%
|
8.72
|
USD 2,468
|
|
|
2012-10-29 |
2012-10-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,209
-100.0%
9.71
USD 21,449
|
2,209
-100.0%
|
9.71
|
USD 21,449
|
|
|
2012-10-01 |
2012-09-28 |
S
Sale
|
Low Philip S
Chief Science Officer
Executive Director
|
34,000
-8.1%
9.99
USD 339,810
|
34,000
-8.1%
|
9.99
|
USD 339,810
|
|
|
2012-09-27 |
2012-09-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,209
-100.0%
10.28
USD 22,709
|
2,209
-100.0%
|
10.28
|
USD 22,709
|
|
|
2012-08-17 |
2012-08-16 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
10,000
-39.9%
9.65
USD 96,535
|
10,000
-39.9%
|
9.65
|
USD 96,535
|
|
|
2012-06-07 |
2012-06-06 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
24,181
-27.4%
6.60
USD 159,674
|
24,181
-27.4%
|
6.60
|
USD 159,674
|
|
|
2012-06-07 |
2012-06-06 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
290,719
-27.4%
6.60
USD 1,919,705
|
290,719
-27.4%
|
6.60
|
USD 1,919,705
|
|
|
2012-06-07 |
2012-06-05 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
783
-0.9%
6.60
USD 5,170
|
783
-0.9%
|
6.60
|
USD 5,170
|
|
|
2012-06-07 |
2012-06-05 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
9,417
-0.9%
6.60
USD 62,180
|
9,417
-0.9%
|
6.60
|
USD 62,180
|
|
|
2012-05-18 |
2012-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
2,142
-2.3%
6.65
USD 14,246
|
2,142
-2.3%
|
6.65
|
USD 14,246
|
|
|
2012-05-18 |
2012-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
25,758
-2.3%
6.65
USD 171,306
|
25,758
-2.3%
|
6.65
|
USD 171,306
|
|
|
2012-05-16 |
2012-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
3,071
-3.3%
6.68
USD 20,510
|
3,071
-3.3%
|
6.68
|
USD 20,510
|
|
|
2012-05-16 |
2012-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
36,929
-3.3%
6.68
USD 246,638
|
36,929
-3.3%
|
6.68
|
USD 246,638
|
|
|
2012-05-16 |
2012-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
8,215
-8.0%
6.94
USD 56,974
|
8,215
-8.0%
|
6.94
|
USD 56,974
|
|
|
2012-05-16 |
2012-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
98,785
-8.0%
6.94
USD 685,113
|
98,785
-8.0%
|
6.94
|
USD 685,113
|
|
|
2011-12-22 |
2011-12-21 |
B
Purchase
|
SANDERLING VENTURES MANAGEMENT V
Large shareholder
|
2,200
+6.7%
3.16
USD 6,952
|
2,200
+6.7%
|
3.16
|
USD 6,952
|
|
|
2011-12-22 |
2011-12-21 |
B
Purchase
|
Sanderling Venture Partners V, LP
Large shareholder
|
217,800
+33.3%
3.16
USD 688,248
|
217,800
+33.3%
|
3.16
|
USD 688,248
|
|
